From the acta prize lecture 2014: The periodontalsystemic connection seen from a microbiological standpoint

Acta Odontologica Scandinavica

Volumn 73, Issue 8, 2015, Pages 563-568

  Olsen, Ingar ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Microbiology; Periodontitis; Systemic diseases

Indexed keywords

BACTEREMIA; DISEASES; HUMAN; MICROBIOLOGY; PERIODONTITIS; RISK FACTOR; TOOTH INFECTION;

BACTEREMIA; DISEASE; FOCAL INFECTION, DENTAL; HUMANS; PERIODONTITIS; RISK FACTORS;

EID: 84949202827     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.3109/00016357.2015.1007480     Document Type: Review

References (49)

1. Kumar PS. Oral microbiota and systemic disease. Anaerobe 2013;24:90-3.
2. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Periodontol 2013;84: S8-19.
3. Linden GJ, Herzberg MC; and on behalf of working group 4 of the joint EFP/AAP workshop. Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAA Workshop on Periodontitis and Systemic Disease. J Periodontol 2013;84:S20-3.
4. Reyes L, Herrera D, Kozarov E, Roldán S, Progulske-Fox A. Periodontal bacterial invasion and infection: contribution toatheroscleroticpathology. JClinPeriodontol2013;40:S30-50.
5. Chapple ILC, Genco R; and on behalf of working group 2 of the joint EFP/AAP workshop. Diabetes and periodontal diseases: consensus report of the joint EFP/AAP Workshop on Periodontitis and Systemic Disease. J Clin Periodontol 2013; 40:S106-12.
6. Engebretson S, Kocher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. J Clin Periodontol 2013;40:S153-63.
7. Borgnakke WS, Ylöstalo PV, Taylor GW, Genco RJ. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Clin Periodontol 2013;40: S135-52.
8. Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes-systematic review. J Clin Periodontol 2013;40: S181-94.
9. Sanz M, Kornman K; and on behalf of working group 3 of the joint EFP/AAP workshop. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Disease. J Clin Periodontol 2013;40:S164-9.
10. Madianos PN, Bobetsis YA, Offenbacher S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J Clin Periodontol 2013;40:S170-80.
11. Michalowicz BS, Gustafsson A, Thumbigere-Math V, Buhlin K. The effects of periodontal treatment on pregnancy outcomes. J Clin Periodontol 2013;40:S195-208.
12. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol 2013;40:S70-84.
13. Tonetti MS, Van Dyke TE; and on behalf of working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the joint EFP/AAP) Workshop on Periodontitis and Systemic Disease. J Periodontol 2013;84:S24-9.
14. Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontology 2000;62:271-86.
15. Olsen I. Oral bacteria in cardiovascular disease. In Håheim LL, editor. Oral infections and cardiovascular disease. Texas, USA: Bentham Science Publishers Ltd; 2011. p 35-44.
16. Olsen I, van Winkelhoff AJ. Acute focal infections of dental origin. Periodontol 2000;65:178-89.
17. Takeuchi H, Furuta N, Morisaki I, Amando A. Exit of intracellular Porphyromonas gingivalis from gingival epithelial cells is mediated by endocytic recycling pathway. Cell Microbiol 2011;13:677-91.
18. Olsen I. Update on bacteraemia related to dental procedures. Transfus Apher Sci 2008;39:173-8.
19. Carrion J, Scisci E, Miles B, Sabino GJ, Zeituni AE, Gu Y, et al. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol 2012; 189:3178-87.
20. Armingohar Z, Jørgensen JJ, Kristoffersen AK, Abesha-Belay E, Olsen I. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. J Oral Microbiol 2014;15:6.
21. Gibson FC 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:2801-6.
22. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005;25:e17-e18.
23. Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, et al. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol 2009;24:64-8.
24. Desvarieux M, Demmer RT, Jacobs DR, Papanou PN, Sacco R, Rundek T. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intimamedia thickness: The Oral Infections and Vascular Disease Epidemiology Study. J Am Heart Assoc 2013;2: e000254.
25. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2013;40:S113-34.
26. Otomo-Corgel J, Pucher JJ, Rethman MP, Reynolds MA. State of the science: chronic periodontitis and systemic health. J Evid Base Dent Pract 2012;51:20-8.
27. Gonzales-Martin C, Spratt DA, Allaker RP. Maternal oral origin of Fusobacterium nucleatum in adverse pregnancy outcomes as determined using the 16S-23S rRNA gene intergenic transcribed spacer region. J Med Microbiol 2013;62: 133-44.
28. Cassini MA, Pilloni A, Condò SG, Vitali LA, Pasquantonio G, Cerronic L. Periodontal bacteria in the genital tract: are they related to adverse pregnancy outcome? Int J Immunopathol Pharmacol 2013;26:931-9.
29. Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 1992;20:740-5.
30. Scannapieco FA, Papandonatos GD, Dunford RG. Associations between oral conditions and respiratory disease in a national sample survey population. Ann Periodontol 1998; 3:251-6.
31. Scannapieco FA, Ho AW. Potential association between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol 2001;72:50-6.
32. Leuckfeld I, Obregon-Whittle MV, Lund MB, Geiran O, Bjørtuft Ø, Olsen I. Severe chronic obstructive pulmonary disease: association with marginal bone loss in periodontitis. Respir Med 2008;102:488-94.
33. Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006;24:656-63.
34. Témoin S, Chakaki A, Askari A, El-Halaby A, Fitzgerald S, Marcus RE, et al. Identification of oral bacterial DNA in synovial fluid of patients with arthritis with native and failed prosthetic joints. J Clin Rheumatol 2012;18:117-21.
35. Ogrendik M. Does periodontopathic bacterial infection contribute to the etiopathogenesis of the autoimmune disease rheumatoid arthritis? Discov Med 2012;13:349-55.
36. Kinloch AJ, Alzabin S, Brintnell W, Wilson E, Barra L, Wegner N, et al. Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian a-enolase and arthritis in DR4-IE-transgenic mice. Arthritis Rheum 2011;63:3818-23.
37. Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog 2013;9:e1003627.
38. Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009;80:535-40.
39. Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. Antibodies to periodontal organisms are associated with decreased kidney function-The dental atherosclerosis risk in communities study. Blood Purif 2007;25:125-32.
40. Siribamrungwong M, Puangpanngam K. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients. Ren Fail 2012;34:171-5.
41. Mizutani K, Park K, Mima A, Katagiri S, King GL. Obesityassociated gingival vascular inflammation and insulin resistance. J Dent Res 2014;93:596-601.
42. Allen-Vercoe E, Jobin C. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett 2014;162: 54-61.
43. Atanasova KR, Yilmaz O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol 2014;29:55-66.
44. D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. Association of the metabolic syndrome with severe periodontitis in a large US population-based survey. J Clin Endocrinol Metab 2008;93:3989-94.
45. Stein PS, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, et al. Serum antibodies to periodontal pathogens are risk factors for Alzheimer’s disease. Alzheimer Dementia 2012;8:196-203.
46. Poole S, Singhrao SK, Chukkapalli S, Rivera M, Velsko I, Kesavalu L, et al. Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-/-mice brains. J Alzheimers Dis 2015;43:67-80.
47. Swidsinski A, Dörffel Y, Loening-Baucke V, Tertychnyy A, Biche-Ool S, Stonogin S, et al. Mucosal invasion by fusobacteria is a common feature of acute appendicitis in Germany, Russia, and China. Saudi J Gastroenterol 2012; 18:55-8.
48. Pérez-Chaparro PJ, Gonçalves C, Figueiredo LC, Faveri M, Lobão E, Tamashiro N, et al. Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res 2014;93:846-58.
49. Olsen I, Preza D, Aas JA, Paster BJ. Cultivated and not-yetcultivated bacteria in oral biofilms. Microb Ecol Health Dis 2009;21:65-71.